Dr. Sasank Raheel Peramsetty, MD

Claim your profileto add your photoNo reviews yetRate & review

Family medicine in Tuscaloosa, AL · First Care, LLC

No reviews yet. Be the first to review

Accepts Medicare assignment

Family medicine

Book an appointmentCall to book · (205) 507-1100

Office

1718 Veterans Memorial Pkwy Ste A, Tuscaloosa, AL 35404

(205) 507-1100

Call the office

Details

NPI

1225666175

Specialty

Family Medicine

Background and affiliations

Gender: Male
Medical school: University of Alabama School of Medicine · graduated 2020
Practice group: First Care, LLC · 11 clinicians
Offers telehealth: No
Accepts Medicare assignment: Yes

Practice locations

1251 McFarland Blvd NE, Tuscaloosa, AL 35406 · (205) 349-2323
1718 Veterans Memorial Pkwy Suite C, Tuscaloosa, AL 35404 · (205) 553-1900
1718 Veterans Memorial Pkwy A, Tuscaloosa, AL 35404 · (205) 507-1100
1771 Skyland Blvd E, Tuscaloosa, AL 35405 · (205) 523-7483

Industry payments

In 2025, drug and medical-device companies reported $154 in general payments to Sasank Raheel Peramsetty (7 payments). Largest: Exact Sciences Corporation ($37.16); ABBVIE INC. ($32.83); Novo Nordisk Inc ($25.33). Reported under the federal Open Payments program.

Insurance

Accepts Medicare assignment.

Medicare activity

2024 Medicare-billed services:

Hemoglobin A1c testing Medicare annual wellness and welcome visits Depression screening

Billed services and units in Original Medicare Part B, 2024.

Scroll the table sideways to see every column.

Original Medicare activity · 2024
HCPCS	Billed services / units	Beneficiaries in this row	Service description (English)	Billing setting
36415	11	11	Insertion of needle into vein for collection of blood sample	Non-facility
71046	64	63	X-ray of chest, 2 views	Non-facility
81002	15	13	Urinalysis, manual test	Non-facility
81003	27	25	Automated urinalysis test	Non-facility
82947	17	17	Blood glucose (sugar) level	Non-facility
83036	23	22	Hemoglobin a1c level	Non-facility
87804	194	94	Detection test by immunoassay with direct visual observation for influenza virus	Non-facility
87811	98	92	Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)	Non-facility
87880	33	33	Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)	Non-facility
94640	15	15	Inhalation treatment for airway obstruction or sputum production	Non-facility
96372	277	161	Injection of drug or substance under skin or into muscle	Non-facility
99203	16	16	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	Non-facility
99204	33	33	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	Non-facility
99213	188	162	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	Non-facility
99214	176	164	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	Non-facility

More Medicare services (2)

Scroll the table sideways to see every column.

Original Medicare activity · 2024
HCPCS	Billed services / units	Beneficiaries in this row	Service description (English)	Billing setting
G0439	20	20	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	Non-facility
G0444	14	14	Annual depression screening, 5 to 15 minutes	Non-facility

Drug billing units (6)

Drug units follow each billing code’s definition.

Scroll the table sideways to see every column.

Original Medicare activity · 2024
HCPCS	Drug billing units	Beneficiaries in this row	Service description (English)	Billing setting
J0696	435	103	Injection, ceftriaxone sodium, per 250 mg	Non-facility
J1100	411	101	Injection, dexamethasone sodium phosphate, 1 mg	Non-facility
J1885	70	33	Injection, ketorolac tromethamine, per 15 mg	Non-facility
J3420	14	14	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	Non-facility
J7613	14	14	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	Non-facility
J7644	14	14	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	Non-facility